On October 30, Luoqi Biology was invited to participate in the "Opening Ceremony of the 8th China Innovation and Entrepreneurship Competition (Shanghai) and 2019 Entrepreneurship in Shanghai International Innovation and Entrepreneurship Competition". At the ceremony, relevant leaders presented awards to the winners of the 2018 "Entrepreneurship in Shanghai" International Innovation and Entrepreneurship Competition.

There are 6520 small and micro group enterprises in this competition. After fierce competition, Luoqi Biology, relying on the high starting point of nano-antibody drug research and development level and the integrated, systematic and comprehensive professional research and development platform, won the award of the winner of the biomedical small and micro group for the whole process from the discovery of nano-antibody drug molecules to preclinical research, and successfully entered the national finals of the 7th China Innovation and Entrepreneurship Competition in 2018, The National Finals will be held in Guangzhou on November 12-15.

The 2018 "Entrepreneurship in Shanghai" International Innovation and Entrepreneurship Competition and the 7th China Innovation and Entrepreneurship Competition (Shanghai) will gather innovative enterprises, innovative elements and talents at home and abroad on the platform of the competition, stimulate the enthusiasm of the whole society for innovation and entrepreneurship, and create a number of technology and entrepreneurship stars.

Loqi Biology focuses on innovative antibody drugs, is committed to breaking the patent barriers of foreign nanoantibodies, building a Chinese camel antibody drug brand, and promoting the innovative development of nanoantibody technology in the fields of tumor immunity and autoimmune disease treatment!

About novamab